1. Home
  2. DAO vs DVAX Comparison

DAO vs DVAX Comparison

Compare DAO & DVAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Youdao Inc. each representing one

DAO

Youdao Inc. each representing one

HOLD

Current Price

$10.95

Market Cap

1.2B

Sector

Real Estate

ML Signal

HOLD

Logo Dynavax Technologies Corporation

DVAX

Dynavax Technologies Corporation

HOLD

Current Price

$15.44

Market Cap

1.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAO
DVAX
Founded
2006
1996
Country
China
United States
Employees
N/A
N/A
Industry
Other Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.3B
IPO Year
2019
2004

Fundamental Metrics

Financial Performance
Metric
DAO
DVAX
Price
$10.95
$15.44
Analyst Decision
Hold
Analyst Count
0
5
Target Price
N/A
$26.50
AVG Volume (30 Days)
106.8K
4.3M
Earning Date
02-19-2026
02-19-2026
Dividend Yield
N/A
N/A
EPS Growth
155.59
N/A
EPS
0.17
N/A
Revenue
$798,421,874.00
$330,514,000.00
Revenue This Year
$5.23
$24.63
Revenue Next Year
$13.46
$15.85
P/E Ratio
$68.17
N/A
Revenue Growth
N/A
26.73
52 Week Low
$6.30
$9.20
52 Week High
$11.82
$15.49

Technical Indicators

Market Signals
Indicator
DAO
DVAX
Relative Strength Index (RSI) 64.15 89.03
Support Level $8.38 $10.78
Resistance Level $11.49 $15.43
Average True Range (ATR) 0.50 0.14
MACD 0.28 0.34
Stochastic Oscillator 81.67 98.97

Price Performance

Historical Comparison
DAO
DVAX

About DAO Youdao Inc. each representing one

Youdao Inc develops and markets software applications. It engages in developing technologies to provide learning content, applications, and solutions. The firm operates in three segments: Learning services, Smart devices, and Online marketing services. The majority of its revenue comes from the Learning services segment, which generates revenues from online courses, mainly including Youdao Premium Courses, NetEase Cloud Classroom, and China University MOOC. The learning products segment includes sales of smart devices such as the Youdao Dictionary Pen and the Youdao Pocket Translator. Geographically, all of its revenue is generated from the People's Republic of China.

About DVAX Dynavax Technologies Corporation

Dynavax Technologies Corp is a biopharmaceutical company. The company focuses on leveraging the power of the body's innate and adaptive immune responses through toll-like receptor stimulation. Its current product candidates are being investigated for use in multiple cancer indications as a vaccine for the prevention of HEPLISAV-B (Hepatitis B Vaccine (Recombinant), Adjuvanted), operates in the business segment of discovery, development, and commercialization of novel vaccines. Its Toll-like Receptor Immune Modulation Platform technology plays a vital role in innate immunity and subsequent adaptive immunity. The company generates the vast majority of its revenue from the sale of its CpG 1018 product and HEPLISAV-B.

Share on Social Networks: